More data to guide patient conversations and decisions... "Adverse event data from blinded randomised trials do not support causal relationships between statin therapy and most conditions listed in product labels as potential undesirable effects..." https://t.co/SWZNC7Sqbw
📢 Announcing a fresh look for your #TRCHealthcare print letter! We've enhanced the layout to make our trusted, evidence-based content even easier to read and apply.
Learn more about the new design: https://t.co/4cM70yrH76
#Healthcare#ContinuingEducation#PharmacistLetter
New research shows that just 7,000 steps/day is associated w/ clinically meaningful ↗️ in health outcomes, including reductions in #CVD incidence & death – & offering a more realistic 🎯 than the previously touted 10,000 steps/day.
Read more: https://t.co/x5AVK4NpT2 #CardioX
Clinical pharmacists led virtual visits for CGM initiation & data interpretation, provided pt education & therapy implications, created education & actionable recommendations for providers & assisted with Rx coverage. https://t.co/nJ73JXo4n8
The world’s leading natural medicines database just got a powerful upgrade. Meet the new NatMed Pro—trusted by the NIH and thousands of healthcare professionals. Now faster, sleeker & packed with enhanced tools. Explore now: https://t.co/GfCZ3Vm3zZ
It’s #WNW with the recently published results ZENITH in @NEJM. This study found that sotatercept was superior to placebo for high risk PAH patients on maximally tolerated background therapy. Is sotatercept the new breakthrough therapy for PAH??
https://t.co/ICF3VcTJzR
@accpcardprn@JACCPJournal Also worth thinking through what factors should be considered if a patient chooses a compounded product. Is it from an accredited compounder? Is certificate of analysis available for ingredients? What else?
How to be a better critical thinker:
1. Be 10% more skeptical of people you agree with—and 10% more charitable to people you disagree with
2. Look for flaws in ideas you like—and strengths in arguments you dislike
3. Learn from sources that engage with competing ideas
🍊 Rumor vs. Truth Podcast is LIVE! 🍊Does your morning grapefruit juice really mess with your meds? Our premiere episode tackles the truth about fruit juice and medication interactions. Let’s squeeze out the facts! Listen now: https://t.co/NPQT6QfDxq
It’s #WhatsNewWednesday! Check out TIGHT K trial published in @JAMA_current to see if tight or relaxed potassium control prevented AF after CABG ⬇️
https://t.co/o8YURdnKfY
This has been needed for a long time!
Redefining obesity
A new report of @TheLancetEndo commission that overrides current BMI categories and better defines features and pathophysiologic consequences of pre-clinical and clinical obesity
https://t.co/iH7NC2tCJ5 open-access
(such as an athlete with no fat excess is not obese, but is according to current BMI based definition)
Power is fleeting. Respect is lasting.
Reputation is not a function of wealth, fancy titles, or prestigious memberships. It's a matter of what we contribute and how we treat others.
Admiration is earned through actions, not positions. The best way to be valued is to add value.
https://t.co/l6YaBz236P
🎉 Did you know you can give 15% off a new subscription to your friends or colleagues, and earn a $20 Visa gift card? It’s simple: you refer, they save, and you get rewarded! Earn rewards for your recommendations—start sharing now: https://t.co/eCoYKA9gw1
It’s #WhatsNewWednesday! New registry data suggest that most patients hospitalized with new onset HFrEF are eligible for quadruple GDMT-but fewer than 1 in 6 get it at discharge. Let's aim higher🎯
https://t.co/6dHDksnL9s
We don't need to debate whether it's better to be a generalist or a specialist. The world needs both.
Specialists excel at zooming in. They see the details to deepen our knowledge.
Generalists excel at zooming out. They see around corners to broaden our view.
Another day, another #ThrowbackThursday —
Today, we are diving into heart transplant with the follow-up from the SCHEDULE study, which investigated mTOR inhibitors and early CNI withdrawal! @TheJHLT
It’s #WhatsNewWednesday! See new ESC statement on peripartum heart failure...with considerations from pre-conception to postpartum.
Check it out ����
https://t.co/VkDIAWLNFQ
It’s #WhatsNewWednesday! @HyperAHA article reviews practical steps to manage orthostatic hypotension...including this figure stratifying OH risk of BP meds.
Check it out 👇
https://t.co/e6zQ8h0CRl